User Tools

Site Tools


parkinsons

Parkinson's disease

see also:

Introduction

  • slowly progressive degenerative disorder of the CNS mainly starting in those aged over 60yrs (when it occurs before age 50yrs it is called early-onset PD)
  • motor impairments (“parkinsonism”) arise from the death of cells in the substantia nigra (in the basal ganglia within the midbrain) leading to a dopamine deficit.
  • 1st detailed description was made by English doctor James Parkinson in 1817

Epidemiology

  • affects 1% of those aged over 60yrs
  • male:female ratio is 3:2

Risk factors

  • coffee, tea drinking and tobacco smoking appear to offer reduced risk
  • genetic factors
  • pesticide / herbicide exposure eg. paraquat seems to double risk in those who live near where paraquat is sprayed such as grain fields
  • PH head injuries
  • low serum urate levels have been correlated with increased risk

Clinical features

  • early cognitive features
    • 19% have cognitive impairments at time of diagnosis (most patients present with motor symptoms first)
      • those who develop dementia before or at the same time of PD motor symptoms are usually given the diagnosis of dementia with Lewy bodies
    • executive functioning impairments
      • multitasking, switching tasks, and solving problems
    • trouble recalling information but their long-term memory function generally remains intact
    • attention difficulties
      • trouble maintaining focus, especially as the complexity of a situation increases
    • slowed thinking or processing, also known as bradyphrenia
      • problem-solving, conversations
    • impaired word finding, naming objects, generating words, comprehension, and verbal concepts
    • visual-spatial impairments
      • difficulties in perceiving, processing, discriminating, and acting on visual information around the person
  • motor impairments
    • reduced arm movements when walking
    • reduced eye blinking
    • monotone voice
    • flattened facial expression range
    • Parkinsonian tremor
    • difficulty initiating movements resulting in increased falls
  • autonomic dysfunction
    • orthostatic hypotension and falls risk
    • constipation
    • impaired stomach emptying (gastric dysmotility)
  • further, later, cognitive impairments may include
    • psychosis - occurs in 50% and may herald onset of dementia
    • apathy
    • anhedonia
    • depression (esp. if early-onset PD, women, PH depression, severe motor symptoms)

Diagnosis

  • primarily clinical

DDx

other conditions that affect the substantia nigra

  • toxins which can cause parkinsonism include:
    • manganese
    • carbon disulfide
    • trichloroethylene (TCE)
  • reversible parkinsonism may be caused by medications such as:
    • phenothiazines (chlorpromazine, promazine, etc.)
    • butyrophenones (haloperidol, benperidol, etc.)
    • metoclopramide
    • tetrabenazine
  • vascular parkinsonism
    • the presence of Parkinson's disease symptoms combined with findings of vascular events (such as a cerebral stroke).
  • multiple system atrophy (MSA)
    • MSA includes disorders that historically had been referred to as Shy-Drager syndrome, olivopontocerebellar atrophy, and striatonigral degeneration
  • progressive supranuclear palsy
  • corticobasal degeneration
  • dementia with Lewy bodies
  • brain tumours
  • Alzheimer's disease
  • concussions, repetitive brain trauma
  • encephalitis
  • Huntington's disease

Prognosis

  • average life expectancy following diagnosis is between 7 and 15 years

Mx

  • initial treatment options include:
    • levodopa (L-DOPA)
    • MAO-B inhibitors
    • dopamine agonists
  • over time these become less effective and these may also cause:
    • involuntary movement disorder
    • dopamine dysregulation syndrome including impulse-control disorders, gambling, compulsive sexual behaviours, etc
    • “punding” - complicated, repetitive, aimless, stereotyped behaviors occur for many hours
  • surgery to place microelectrodes for deep brain stimulation has been used to reduce motor symptoms in severe cases where drugs are ineffective
parkinsons.txt · Last modified: 2024/10/27 21:47 by gary1

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki